Tumor infiltrating T lymphocyte therapy(Aeonvital Biomedicine)

肿瘤浸润T淋巴细胞（北京循生生物）

Report date: 2022/08/25 13:40:05

Base Information

Drug NameTumor infiltrating T lymphocyte therapy(Aeonvital Biomedicine)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesAeonvital Biomedicine Research Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAeonvital Biomedicine Research Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A